Contents of JRRD Volume 43, Number 1

1 Use of medical informatics for management of multiple sclerosis using a chronic-care model

Michael Hatzakis Jr, MD; Craig Allen, MS; Mark Haselkorn, PhD; Stephen M. Anderson, MS;
Paul Nichol, MD; Charles Lai, MS; Jodie K. Haselkorn, MD, MPH

17 Veterans Health Administration multiple sclerosis surveillance registry: The problem of case-finding
from administrative databases

William J. Culpepper II, MA; Mary Ehrmantraut, RN, MS; Mitchell T. Wallin, MD, MPH;
Kathleen Flannery, PharmD; Douglas D. Bradham, DrPH

25 Exploring educational needs of multiple sclerosis care providers: Results of a care-provider survey

Aaron P. Turner, PhD; Christine Martin, PhD; Rhonda M. Williams, PhD; Kelly Goudreau, DSN, RN; James D. Bowen, MD; Michael Hatzakis Jr, MD; Ruth H. Whitham, MD; Dennis N. Bourdette, MD;
Lynne Walker, RN, BSN, CRRN; Jodie K. Haselkorn, MD, MPH

35 Quality of life for veterans with multiple sclerosis on disease-modifying agents: Relationship to disability

Joseph B. Guarnaccia, MD; Mihaela Aslan, PhD; Theresa Z. O'Connor, PhD; MaryAnn Hope, MS;
Lewis Kazis, ScD; C. Michael Kashner, PhD; John Booss, MD

45 Depression and multiple sclerosis: Review of a lethal combination

Mitchell T. Wallin, MD, MPH; Jeffrey A. Wilken, PhD; Aaron P. Turner, PhD; Rhonda M. Williams, PhD;
Robert Kane, PhD

63 Cognitive dysfunction in multiple sclerosis: Assessment, imaging, and risk factors

Mitchell T. Wallin, MD, MPH; Jeffrey A. Wilken, PhD; Robert Kane, PhD

73 Correlations of Perceived Deficits Questionnaire of Multiple Sclerosis Quality of Life Inventory
with Beck Depression Inventory and neuropsychological tests

Jesus Lovera, MD, MSPH; Bridget Bagert, MD, MPH; Kyle Smoot, MD; Katherine Wild, PhD;
Rachel Frank, BA; Kristin Bogardus, BS; Barry S. Oken, MD; Ruth H. Whitham, MD;
Dennis N. Bourdette, MD

83 Cognition and fatigue in multiple sclerosis: Potential effects of medications with central nervous
system activity

Barry S. Oken, MD; Kristin Flegal, BS; Daniel Zajdel; Shirley S. Kishiyama, MA;
Jesus Lovera, MD, MSPH; Bridget Bagert, MD, MPH; Dennis N. Bourdette, MD

91 Some effects of multiple sclerosis on speech perception in noise: Preliminary findings

M. Samantha Lewis, PhD; David J. Lilly, PhD; Michele Hutter, MS; Dennis N. Bourdette, MD;
Julie Saunders, RN, MSN, ANP; Stephen A. Fausti, PhD

99 Complementary and alternative medicine use in veterans with multiple sclerosis: Prevalence
and demographic associations

Duncan G . Campbell, PhD; Aaron P. Turner, PhD; Rhonda M. Williams, PhD; Michael Hatzakis Jr, MD; James D. Bowen, MD; Arthur Rodriquez, MD, MS; Jodie K. Haselkorn, MD, MPH

111 Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment
of central nervous system inflammation and degeneration

Susan I. V. Judge, PhD; Jennifer M. Lee, BS; Christopher T. Bever Jr, MD; Paul M. Hoffman, MD

123 Oligodendrocyte cell death in pathogenesis of multiple sclerosis: Protection of oligodendrocytes
from apoptosis by complement

Cornelia Cudrici, MD; Teodora Niculescu, MD; Florin Niculescu, MD, PhD; Moon L. Shin, MD;
Horea Rus, MD, PhD

137 Guidelines for Contributors (Abbreviated Version)

Scientific/Technical Articles